EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

Starting soon

Conditions studied: Migraine Disorders, Chronic Migraine Headache, Migraine

In brief

EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.

Key facts

Study ID

NCT07652034

Run by

Cortex Neurovascular

People needed

50

Starts

2026-07-01

Expected to finish

2028-06-01

Last updated by the study team

2026-06-18

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 to 64 years
• Diagnosis of migraine
• Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation
• Able and willing to provide informed consent
• Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments

You may not qualify if…

• Age under 18 years
• Pregnancy at the time of enrollment
• Inability to provide informed consent
• Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
• Insufficient clinical or patient-reported outcome data for the planned analyses

Where it is running

• Cortex Neurovascular / TRA Union — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.